Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic

Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers

(2011) C. Jackson et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Meningococcal serogroup B vaccines: will they live up to expectations?

(2011) Wendell D Zollinger et al.   Expert Review of Vaccines

Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

(2010) Jamie Findlow et al.   CLINICAL INFECTIOUS DISEASES

Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand

(2009) Patricia Priest et al.   CANCER CAUSES & CONTROL

Fast Tracking the Vaccine Licensure Process to Control an Epidemic of Serogroup B Meningococcal Disease in New Zealand

(2009) Diana Lennon et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine

(2009) Sharon H. Wong et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

THE AUTHORS REPLY

(2008) C. Kelly et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

RE: "A PROSPECTIVE STUDY OF THE EFFECTIVENESS OF THE NEW ZEALAND MENINGOCOCCAL B VACCINE"

(2008) D. Lennon et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Phase II meningococcal B vesicle vaccine trial in New Zealand infants

(2008) C Jackson et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

(2008) Y. Galloway et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY